Eledon Pharmaceuticals, Inc. (ELDN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 113.57M | 135.69M | 96.3M | 111.4M | 127.72M | 143.73M | 81.51M | 87.22M | 47.98M | 56.13M | 62.99M | 73.62M | 48.9M | 59.52M | 67.56M | 72.79M | 79.33M | 88.35M | 95.56M | 102.58M |
| Cash & Short-Term Investments | 111.09M | 133.34M | 93.4M | 107.57M | 124.88M | 140.18M | 78.19M | 83.61M | 42.86M | 51.1M | 59.61M | 71.38M | 46.48M | 56.41M | 65.89M | 70.46M | 76.68M | 84.83M | 94.04M | 101.13M |
| Cash Only | 6.15M | 22.81M | 3.67M | 5.74M | 8.5M | 20.55M | 6.75M | 26.04M | 5.66M | 4.61M | 3.67M | 40.95M | 46.48M | 56.41M | 65.89M | 70.46M | 76.68M | 84.83M | 94.04M | 101.13M |
| Short-Term Investments | 104.94M | 110.53M | 89.73M | 101.83M | 116.39M | 119.63M | 71.44M | 57.57M | 37.21M | 46.49M | 55.94M | 30.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 583K | 514K | 753K | 705K | 761K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 9K | 11K | 14K | 10K | 55K | 729K | 442K | 157K | 54K | 90K | 90K | 238K | 47K | 28K | 57K | 32K | 17K | 34K | 11K | 11K |
| Total Non-Current Assets | 33.09M | 33.32M | 33.56M | 33.51M | 33.59M | 33.67M | 33.07M | 33.26M | 32.84M | 32.94M | 33.08M | 33.16M | 33.4M | 33.27M | 82.02M | 81.92M | 82.05M | 82.2M | 81.61M | 81.72M |
| Property, Plant & Equipment | 530K | 613K | 694K | 773K | 850K | 926K | 471K | 621K | 270K | 365K | 459K | 553K | 647K | 739K | 832K | 581K | 675K | 768K | 222K | 267K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.65M | 48.65M | 48.65M | 48.65M | 48.65M | 48.65M |
| Intangible Assets | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 177K | 322K | 476K | 346K | 354K | 363K | 210K | 255K | 185K | 186K | 233K | 224K | 369K | 150K | 155K | 303K | 344K | 400K | 356K | 422K |
| Total Assets | 146.67M | 169.01M | 129.86M | 144.91M | 161.31M | 177.41M | 114.58M | 120.48M | 80.82M | 89.07M | 96.07M | 106.78M | 82.31M | 92.79M | 149.59M | 154.71M | 161.38M | 170.55M | 177.17M | 184.31M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -9.08% | -4.73% | 13.34% | 20.27% | 99.59% | 99.18% | 19.26% | 12.83% | -1.81% | -4.02% | -35.78% | -30.98% | -49% | -45.59% | -15.57% | -16.06% | -15.81% | -13.51% | -8% | 1655.12% |
| Total Current Liabilities | 13.46M | 18.34M | 14.3M | 13.72M | 9.19M | 11.58M | 12.49M | 6.03M | 4.25M | 3.9M | 2.9M | 4.9M | 5.48M | 6.47M | 6.28M | 3.28M | 2.96M | 4.4M | 4.05M | 2.68M |
| Accounts Payable | 6.58M | 3.63M | 4.63M | 5.83M | 2.9M | 5.83M | 5.86M | 2.15M | 1.86M | 967K | 465K | 2.2M | 2.85M | 2.2M | 3.86M | 1.32M | 1.03M | 1.81M | 1.6M | 857K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 369K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.86M | 4.18M | 3.21M | 2.25M | 1.32M | 1.6M | 2.06M | 1.56M | 0 | 2M | 1.54M | 1.42M | 845K | 0 | 0 | 0 | 814K | 1.51M | 0 | 656K |
| Current Ratio | 8.44x | 7.40x | 6.74x | 8.12x | 13.91x | 12.42x | 6.53x | 14.48x | 11.30x | 14.41x | 21.73x | 15.02x | 8.93x | 9.19x | 10.76x | 22.22x | 26.82x | 20.07x | 23.62x | 38.32x |
| Quick Ratio | 8.44x | 7.40x | 6.74x | 8.12x | 13.91x | 12.42x | 6.53x | 14.48x | 11.30x | 14.41x | 21.73x | 15.02x | 8.93x | 9.19x | 10.76x | 22.22x | 26.82x | 20.07x | 23.62x | 38.32x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 32.75M | 69.58M | 80.2M | 25.16M | 37.54M | 47.69M | 26.03M | 122.96M | 91.3M | 77.96M | 1.83M | 1.94M | 2.04M | 2.13M | 2.21M | 2.05M | 2.1M | 2.15M | 2.38M | 3.11M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 186K | 283K | 376K | 467K | 555K | 640K | 315K | 386K | 0 | 0 | 83K | 184K | 284K | 383K | 461K | 299K | 350K | 400K | 45K | 90K |
| Deferred Tax Liabilities | 2.19M | 2.19M | 2.18M | 2.18M | 2.18M | 2.18M | 1.75M | 1.75M | 0 | 1.75M | 1.75M | 1.75M | 1.75M | 0 | 0 | 0 | 1.75M | 1.75M | 0 | 3.02M |
| Other Non-Current Liabilities | 30.38M | 67.11M | 77.64M | 22.51M | 34.8M | 44.87M | 23.96M | 120.82M | 91.3M | 76.21M | 0 | 0 | 0 | 1.75M | 1.75M | 1.75M | 0 | 0 | 2.33M | 0 |
| Total Liabilities | 46.21M | 87.92M | 94.5M | 38.88M | 46.73M | 59.27M | 38.52M | 128.98M | 95.55M | 81.86M | 4.73M | 6.84M | 7.51M | 8.61M | 8.49M | 5.33M | 5.06M | 6.55M | 6.42M | 5.78M |
| Total Debt | 555K | 641K | 722K | 803K | 880K | 954K | 501K | 655K | 284K | 383K | 479K | 574K | 668K | 746K | 839K | 586K | 678K | 769K | 222K | 269K |
| Net Debt | -5.6M | -22.17M | -2.95M | -4.94M | -7.62M | -19.59M | -6.25M | -25.38M | -5.37M | -4.23M | -3.19M | -40.37M | -45.82M | -55.66M | -65.05M | -69.87M | -76M | -84.06M | -93.82M | -100.86M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | - | - | 0.05x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -30.59x | - | - | - | - | - | - | -1971.80x | - | - | - |
| Total Equity | 100.46M | 81.08M | 35.36M | 106.03M | 114.58M | 118.14M | 76.06M | -8.5M | -14.73M | 7.21M | 91.33M | 99.95M | 74.79M | 84.18M | 141.09M | 149.38M | 156.32M | 164M | 170.75M | 178.52M |
| Equity Growth % | -12.32% | -31.37% | -53.51% | 1347.24% | 877.97% | 1539.01% | -16.73% | -108.51% | -119.69% | -91.44% | -35.27% | -33.09% | -52.15% | -48.67% | -17.37% | -16.32% | -14.99% | -13.96% | 693.96% | 1808.09% |
| Book Value per Share | 0.89 | 1.07 | 0.46 | 1.37 | 1.49 | 1.98 | 1.37 | -0.20 | -0.49 | 0.30 | 3.05 | 4.16 | 5.24 | 6.11 | 9.89 | 10.47 | 10.91 | 11.46 | 11.52 | 12.05 |
| Total Shareholders' Equity | 100.46M | 81.08M | 35.36M | 106.03M | 114.58M | 118.14M | 76.06M | -8.5M | -14.73M | 7.21M | 91.33M | 99.95M | 74.79M | 84.18M | 141.09M | 149.38M | 156.32M | 164M | 170.75M | 178.52M |
| Common Stock | 76K | 75K | 60K | 60K | 60K | 60K | 41K | 39K | 25K | 24K | 24K | 23K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K |
| Retained Earnings | -440.23M | -401.2M | -390.76M | -373.3M | -362.08M | -355.59M | -310.97M | -387.94M | -343.03M | -319.4M | -233.56M | -223.22M | -213.64M | -202.87M | -144.48M | -134.01M | -124.76M | -114.9M | -106.09M | -96.28M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -72K | 24K | 9K | -48K | -18K | 26K | 102K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |